Total
0
Shares
Source: Sprout AI.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Sprout AI (SPRT) has been selected by JT Medical to provide cultivation technology for controlled substances
  • JT Medical will use Sprout AI’s proprietary cultivation habitats to cultivate the various plants, which include psilocybin mushroom, cannabis, and peyote and their derivatives
  • Sprout AI will deliver several units to JT Medical over the next 12 months
  • Sprout AI is a vertical farming technology company
  • Sprout AI (SPRT) is up 1.25 per cent, trading at $0.81 per share

Sprout AI (SPRT) has been selected by JT Medical to provide cultivation technology for controlled substances.

Based in Pennsylvania, JT Medical is moving forward to obtain its license to cultivate, process, and distribute controlled plants for medical research and development.

JT Medical will use Sprout AI’s proprietary cultivation habitats to cultivate the various plants, which include psilocybin mushroom, cannabis, and peyote and their derivatives.

The habitats will be installed, set up, and managed by TheraCann International Benchmark Corporation, which has an existing agreement with JT Medical.

Scott Noerr, co-founder and CFO of JT Medical, commented on the partnership with TheraCann.

“We chose them due to the vast array of managed services they offer, but more importantly, the development they have provided internationally,” he said.

Sprout AI will deliver several units to JT Medical over the next 12 months, based on the receipt of the cultivation request from the Drug Enforcement Administration (DEA).

Chris Bolton, CEO of Sprout AI, commented on the purchase order.

“Utilizing Sprout AI for this DEA medical research license Project further demonstrates Sprout AI’s highest level of plant crop flexibility, quality and repeatability,” he said.

“We are excited,” added Mr. Bolton, “that our inclusion in this project is yet another step in further establishing Sprout AI as a leading global provider of sustainable vertical farming solutions for the cultivation of plant-based medicinal research and development grade products.”

Sprout AI is a vertical farming technology company. The company plans, designs, manufactures and assembles sustainable and scalable AI-controlled vertical cultivation equipment.

Sprout AI (SPRT) is up 1.25 per cent, trading at $0.81 per share as of 12:11 pm ET.

More From The Market Herald

" Sprout AI Inc. (CSE:SPRT) addresses short selling market activity

Sprout AI Inc. (SPRT) wishes to address the trading activity that took place on October 20th.
BioHarvest Sciences - David Tsur

" BioHarvest Sciences (CSE:BHSC) appoints David Tsur to its board of directors

BioHarvest Sciences (BHSC) has announced that, effective immediately, David Tsur will serve as a non-executive director of the company.
Mary Agrotech - CEO, Frank Qin (left).

" Mary Agrotech (CSE:MARY) signs deal with one of China’s largest vertical farms

Mary Agrotech (MARY) has entered a strategic partnership with Changzhi Yufeng Agricultural Technology Development.

" EarthRenew (CSE:ERTH) announces private placement financing

EarthRenew (ERTH) has announced a non-brokered private placement financing for gross proceeds of up to $1,100,000.